Aspira Women's Health Inc.

3.79+0.2400+6.76%Vol 429.03K1Y Perf 49.61%
Sep 23rd, 2021 14:04 DELAYED
BID3.78 ASK3.80
Open3.57 Previous Close3.55
Pre-Market- After-Market-
 - -%  - -
Target Price
12.00 
Analyst Rating
— — 0.00
Potential %
216.62 
Finscreener Ranking
★★★★+     57.57
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
★★★     51.72
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
★★★★     59.53
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
★★★★ —    -
Price Range Ratio 52W %
16.36 
Earnings Rating
Buy
Market Cap424.73M 
Earnings Date
11th Nov 2021
Alpha0.02 Standard Deviation0.35
Beta3.04 

Today's Price Range

3.533.83

52W Range

2.4710.54

5 Year PE Ratio Range

-3.30-4.70

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Week
7.25%
1 Month
-1.39%
3 Months
-37.72%
6 Months
-49.21%
1 Year
49.61%
3 Years
-92.79%
5 Years
-91.22%
10 Years
-76.93%

TickerPriceChg.Chg.%
AWH3.790.24006.76
AAPL146.911.06000.73
GOOG2 841.2622.49000.80
MSFT299.971.39000.47
XOM57.131.92003.48
WFC48.070.99002.10
JNJ165.681.75001.07
FB346.703.49001.02
GE103.805.26005.34
JPM161.635.72003.67
Financial StrengthValueIndustryS&P 500US Markets
9.30
9.50
0.06
0.08
5.60
Leverage Ratio 1.30
ProfitabilityValueIndustryS&P 500US Markets
32.80
-406.60
-401.20
-406.30
5.93
RevenueValueIndustryS&P 500US Markets
5.98M
0.05
21.34
18.48
Earnings HistoryEstimateReportedSurprise %
Q02 2021-0.06-0.060.00
Q01 2021-0.24-0.0579.17
Q04 2020-0.04-0.58-1 350.00
Q03 2020-0.04-0.040.00
Q02 2020--0.04-
Q01 2020--0.04-
Q04 2019--0.03-
Q03 2019--0.04-
Earnings Per EndEstimateRevision %Trend
9/2021 QR-0.080.00-
12/2021 QR-0.080.00-
12/2021 FY-0.250.00-
12/2022 FY-0.273.57Positive
Next Report Date11th Nov 2021
Estimated EPS Next Report-0.08
Estimates Count1
EPS Growth Next 5 Years %-
Volume Overview
Volume429.03K
Shares Outstanding112.07M
Shares Float85.00M
Trades Count1.74K
Dollar Volume3.31M
Avg. Volume595.60K
Avg. Weekly Volume616.02K
Avg. Monthly Volume500.74K
Avg. Quarterly Volume436.09K

Aspira Women's Health Inc. (NYSE: AWH) stock closed at 3.55 per share at the end of the most recent trading day (a 1.72% change compared to the prior day closing price) with a volume of 410.88K shares and market capitalization of 424.73M. Is a component of indices and it is traded on NYSE exchange. The company belongs in the Medical Diagnostics & Research industry, Healthcare sector and employs 53 people. Aspira Women's Health Inc. CEO is Valerie Palmieri.

The one-year performance of Aspira Women's Health Inc. stock is 49.61%, while year-to-date (YTD) performance is -47.09%. AWH stock has a five-year performance of -91.22%. Its 52-week range is between 2.47 and 10.54, which gives AWH stock a 52-week price range ratio of 16.36%

Aspira Women's Health Inc. currently has a PE ratio of -17.50, a price-to-book (PB) ratio of 8.78, a price-to-sale (PS) ratio of 65.22, a price to cashflow ratio of 18.60, a PEG ratio of 2.32, a ROA of -67.09%, a ROC of -77.92% and a ROE of -85.72%. The company’s profit margin is 5.93%, its EBITDA margin is -401.20%, and its revenue ttm is $5.98 Million , which makes it $0.05 revenue per share.

Of the last four earnings reports from Aspira Women's Health Inc., there were 1 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $-0.08 for the next earnings report. Aspira Women's Health Inc.’s next earnings report date is 11th Nov 2021.

The consensus rating of Wall Street analysts for Aspira Women's Health Inc. is (), with a target price of $, which is 0.00% compared to the current price. The earnings rating for Aspira Women's Health Inc. stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Aspira Women's Health Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of 36.00%.

Aspira Women's Health Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 16.46, ATR14 : 0.22, CCI20 : -34.09, Chaikin Money Flow : -0.05, MACD : -0.16, Money Flow Index : 58.54, ROC : -5.59, RSI : 44.55, STOCH (14,3) : 43.94, STOCH RSI : 0.82, UO : 46.18, Williams %R : -56.06), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Aspira Women's Health Inc. in the last 12-months were:

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
5 (100.00 %)
5 (100.00 %)
6 (100.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary Rating---

Aspira Women's Health Inc.

Aspira Womens Health Inc is transforming women's health with the discovery, development, and commercialization of innovative testing options and bio-analytical solutions that help physicians assess risk, optimize patient management and improve gynecologic health outcomes for women. OVA1 plus combines its FDA-cleared products OVA1 and OVERA to detect the risk of ovarian malignancy in women with adnexal masses. ASPiRA GenetiX testing offers both targeted and a more comprehensive genetic testing options with a gynecologic focus. Its focus is on delivering products that allow healthcare providers to stratify risk, facilitate early detection, and optimize treatment.

CEO: Valerie Palmieri

Telephone: +1 512 519-0400

Address: 12117 Bee Caves Road, Building Three, Austin 78738, TX, US

Number of employees: 53

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

48%52%

Bearish Bullish

63%37%

Bearish Bullish

53%47%

News

Stocktwits